T1	Drug 11 15	DTaP
T2	Drug 17 20	IPV
T3	Drug 22 27	PCV13
T4	Drug 32 35	Hib
*	OR T3 T4 T2 T1
T5	Temporal 36 55	prior to enrollment
T6	Reference_point 45 55	enrollment
T7	Scope 11 35	DTaP, IPV, PCV13, or Hib
R1	Has_temporal Arg1:T7 Arg2:T5	
T8	Drug 166 170	DTaP
T9	Drug 172 175	IPV
T10	Drug 177 180	HBV
T11	Drug 182 187	PCV13
T12	Drug 192 195	Hib
T13	Mood 120 139	Anticipated receipt
T14	Temporal 196 241	during the first 60 hours after randomization
T15	Reference_point 228 241	randomization
R2	Has_index Arg1:T14 Arg2:T15	
*	OR T11 T12 T10 T9 T8
T16	Scope 166 195	DTaP, IPV, HBV, PCV13, or Hib
R3	Has_temporal Arg1:T16 Arg2:T14	
R4	Has_mood Arg1:T16 Arg2:T13	
T17	Qualifier 256 262	severe
T18	Condition 263 280	allergic reaction
T19	Condition 287 298	anaphylaxis
T20	Drug 326 345	hepatitis B vaccine
T21	Temporal 305 313	previous
R5	Has_temporal Arg1:T20 Arg2:T21	
R6	Has_qualifier Arg1:T18 Arg2:T17	
T22	Scope 256 280	severe allergic reaction
R7	Subsumes Arg1:T22 Arg2:T19	
R8	AND Arg1:T22 Arg2:T20	
T23	Qualifier 360 366	severe
T24	Condition 367 384	allergic reaction
R9	Has_qualifier Arg1:T24 Arg2:T23	
T25	Condition 391 402	anaphylaxis
T26	Drug 411 454	component of the vaccines used in the study
T27	Drug 465 473	neomycin
T28	Drug 485 496	polymyxin B
T29	Drug 475 480	yeast
*	OR T28 T29 T27
T30	Scope 465 496	neomycin, yeast and polymyxin B
R10	Subsumes Arg1:T26 Arg2:T30	
T31	Scope 360 384	severe allergic reaction
R11	Subsumes Arg1:T31 Arg2:T25	
R12	AND Arg1:T31 Arg2:T26	
T32	Condition 515 522	allergy
T33	Drug 509 514	latex
R13	AND Arg1:T32 Arg2:T33	
T34	Observation 498 505	History
R14	Has_temporal Arg1:T32 Arg2:T34	
T35	Condition 544 575	progressive neurologic disorder
T36	Qualifier 579 592	unknown cause
R15	Has_qualifier Arg1:T35 Arg2:T36	
T37	Qualifier 535 543	unstable
R16	Has_qualifier Arg1:T35 Arg2:T37	
T38	Observation 524 531	History
R17	Has_temporal Arg1:T35 Arg2:T38	
T39	Condition 594 614	Known cause of apnea
T40	Condition 626 646	apnea of prematurity
T41	Negation 615 625	other than
R18	Has_negation Arg1:T40 Arg2:T41	
R19	AND Arg1:T39 Arg2:T40	
T42	Condition 648 670	Cyanotic heart disease
T43	Qualifier 672 682	congenital
T44	Qualifier 686 694	acquired
*	OR T43 T44
T45	Scope 672 694	congenital or acquired
R20	Has_scope Arg1:T42 Arg2:T45	
T46	Non-query-able 697 805	Child or parent/LAR is an immediate relative of study staff or an employee who is supervised by study staff.
T47	Non-query-able 807 1003	Any condition that would, in the opinion of the site investigator, place the participant at an unacceptable risk of injury or render the participant unable to meet the requirements of the protocol
